Home > Legislation > 115th Congress > H.R.2999

H.R.2999 - Patients' Access to Treatments Act of 2017115th Congress (2017-2018) |

Bill

Hide Overview
Sponsor: Rep. McKinley, David B. [R-WV-1] (Introduced 06/22/2017)
Committees: House - Energy and Commerce
Latest Action: House - 06/23/2017 Referred to the Subcommittee on Health.  (All Actions)

Tracker:

This bill has the status Introduced

Here are the steps for Status of Legislation:

  1. Introduced
  2. Passed House
  3. Passed Senate
  4. To President
  5. Became Law

More on This Bill

  • Constitutional Authority Statement
  • CBO Cost Estimates [0]

Subject — Policy Area:

Summary: H.R.2999 — 115th Congress (2017-2018)All Information (Except Text)

There is one summary for H.R.2999. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (06/22/2017)

Patients' Access to Treatments Act of 2017

This bill amends the Public Health Service Act to establish cost sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost sharing structure. Such health plans may not impose higher cost sharing requirements, including copayment and coinsurance, for specialty drugs than for other prescription drugs in a nonpreferred brand name drug tier. If a health plan's formulary contains more than one nonpreferred brand name drug tier, the tier with the lowest cost sharing applies.